|
2014
1. Martinon-Torres F, Gimenez-Sanchez F, Bernaola-Iturbe E, Diez-Domingo J, Jiang Q, Perez JL. A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants. Vaccine. 2014 Sep 8;32(40):5206-11
2. Navarro-Illana P, Aznar J, Diez-Domingo J. Ethical considerations of universal vaccination against human papilloma virus. BMC Med Ethics. 2014;15:29.
3. Navarro-Illana P, Diez-Domingo J, Navarro-Illana E, Tuells J, Aleman S, Puig-Barbera J. "Knowledge and attitudes of spanish adolescent girls towards human papillomavirus infection: where to intervene to improve vaccination coverage". BMC Public Health. 2014;14(1):490.
4. Pérez-Breva L, Villanueva RJ, Villanueva-Oller J, Acedo L, Santonja F, Moraño JA, et al. Optimizing strategies for meningococcal C disease vaccination in Valencia (Spain). BMC Infect Dis. 2014;14(280).
6. Puig-Barbera J, Natividad-Sancho A, Calabuig-Perez J, Lluch-Rodrigo JA, Pastor-Villalba E, Martinez-Ubeda S, et al. Intradermal and virosomal influenza vaccines for preventing influenza hospitalization in the elderly during the 2011-2012 influenza season: A comparative effectiveness study using the Valencia health care information system. Vaccine. 2014 Sep 22;32(42):5447-54.
7. Puig-Barbera J, Natividad-Sancho A, Launay O, Burtseva E, Ciblak MA, Tormos A, et al. 2012-2013 Seasonal Influenza Vaccine Effectiveness against Influenza Hospitalizations: Results from the Global Influenza Hospital Surveillance Network. PLoS One. 2014;9(6):e100497.
8. Puig-Barbera J, Tormos A, Sominina A, Burtseva E, Launay O, Ciblak MA, et al. First-year results of the Global Influenza Hospital Surveillance Network: 2012-2013 Northern hemisphere influenza season. BMC Public Health. 2014 Jun 5;14(1):564.
9. Rodriguez-Galan MA, Perez-Vilar S, Diez-Domingo J, Tuells J, Gomar-Fayos J, Morales-Olivas F, et al. [Adverse reactions to human papillomavirus vaccine in the Valencian Community (2007-2011).]. Anales de Pediatria. 2014 Feb 26.
10. Tuells J. [The public health in historical perspective.]. Gac Sanit. 2014;28:87-8. Spanish.
11. van der Velden MV, Fritz R, Pöllabauer EM, Portsmouth D, Howard MK, Kreil TR, et al.uells J. Safety and immunogenicity of a vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric population. J Infect Dis. 2014 Jan 1;209(1):12-23